Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Open access

Abstract

Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance. To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Although both groups exhibited similar weight gain during the intervention, visceral adipose volume was significantly increased only in subjects consuming fructose. Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption. Similarly, markers of altered lipid metabolism and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concentrations of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption. In addition, fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose. These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci37385

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Research works printed but not linked: 3

  1. Herman, 1970, Fed. Proc., 29, 1302
  2. Schwarz, 1993, Diabetes., 42, A39
  3. Teff, 2009, J. Clin. Endocrinol. Metab.

Cited by

See all 1,765

Metadata

Authors
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L., & Havel, P. J.
Affiliations
  • University of California, Davis (US)
  • University of California, San Francisco (US)
  • United States Department of Agriculture (US)
  • Touro University California (US)
  • UCSF Benioff Children's Hospital (US)
  • Tufts University (US)
  • KineMed (United States) (US)
  • VA Northern California Health Care System (US)
Corresponding author
Havel, Peter J.
Venue
Journal of Clinical Investigation
Published
2009-05-01
Volume
119
Issue
5
Pages
1322-1334
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2146966453
Cited by
1,765
References
86
Citations by year
2026: 56 · 2025: 73 · 2024: 56 · 2023: 96 · 2022: 92 · 2021: 101 · 2020: 113 · 2019: 112 · 2018: 135 · 2017: 105 · 2016: 118 · 2015: 121 · 2014: 135 · 2013: 143 · 2012: 108
FWCI
74.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • American Diabetes Association (UL1 RR024146)
  • U.S. Department of Agriculture (5306‐51530‐016‐00D, UL1 RR024146)
  • Bristol-Myers Squibb
  • Pfizer
  • Sanofi
  • American College of Radiology Imaging Network
  • School of Veterinary Medicine, University of California, Davis
  • KineMed
  • Novo Nordisk
  • Otsuka Pharmaceutical
  • National Institutes of Health (AT‐003545, 5r01hl075675-05, 5r01hl091333-02, HL‐091333, R01 HL-075675, HL‐075675, RR024146)
  • University of California, Davis (95616, RR024146, UL1 RR024146)
  • Agricultural Research Service (5306‐51530‐016‐00D)
  • National Heart, Lung, and Blood Institute (R01 HL-075675, R01 HL-091333, HL-091333, R01HL107256)
  • National Center for Research Resources (RR-024146, 5306-51530-016-00D, UL1RR024146)
  • National Center for Complementary and Integrative Health (AT0-02993, AT0-03545, AT 002599, R21AT002993, R21AT002599)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
dietary fructose, glucose, visceral fat, insulin resistance, insulin sensitivity, dyslipidemia, hepatic de novo lipogenesis, triglycerides, lipoprotein remodeling, oxidized LDL, remnant-like particles, overweight and obesity, weight gain
MeSH terms
Beverages, Blood Glucose, Body Weight, Energy Intake, Double-Blind Method, Eating, Female, Fructose, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, Liver, Male, Middle Aged, Models, Biological, Obesity, Sex Characteristics, Triglycerides, Gene Expression, Dietary Sucrose, Subcutaneous Fat, Intra-Abdominal Fat, Overweight, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. https://app.cochat.ai/papers/10.1172/jci37385
The paper
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., . . . Havel, P. J. (2009). Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci37385

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.